Useful resources |
Remacemide for drug-resistant localization related epilepsy (Cochrane Review) ABSTRACT Background: Epilepsy is a common neurological condition, affecting 0.5% to 1% of the population. Nearly 30% of people with epilepsy have seizures that are refractory to currently available drugs. In response to this problem, potential new drugs are being develop . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |